Helix BioPharma Corp. (HBP.TO)
| Previous Close | 0.5200 |
| Open | 0.5400 |
| Bid | 0.5000 x 0 |
| Ask | 0.5100 x 0 |
| Day's Range | 0.5000 - 0.5500 |
| 52 Week Range | 0.2500 - 1.1600 |
| Volume | 21,747 |
| Avg. Volume | 16,238 |
| Market Cap | 71.978M |
| Beta (5Y Monthly) | -0.19 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0550 |
| Earnings Date | Mar. 16, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.10 |
- ACCESSWIRE
Helix BioPharma Corp. Provides Second Bi-Weekly MCTO Status Update
RICHMOND HILL, ON / ACCESSWIRE / November 15, 2021 / Helix BioPharma Corp.The MCTO does not affect the ability of investors who are not insiders to trade in the securities of the Company.
- ACCESSWIRE
Helix BioPharma Corp. Provides Bi-Weekly MCTO Status Update
RICHMOND HILL, ON / ACCESSWIRE / November 1, 2021 / Helix BioPharma Corp.The MCTO does not affect the ability of investors who are not insiders to trade in the securities of the Company.
- ACCESSWIRE
Helix BioPharma Corp. Announces Delay of Annual Filings
RICHMOND HILL, ON / ACCESSWIRE / October 15, 2021 / Helix BioPharma Corp.In light of the Company's recent change of auditor, previously announced on June 24, 2021 and the departure of the Company's long tenured CEO & CSO effective September 1, 2021, in order to ensure that all internal and audit controls are properly executed, the Company has determined that it will not be able to complete the audit and file the Annual Filings by the Filing Deadline.
